Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Pediatric Endocrinology · Classic Congenital Adrenal Hyperplasia

Growing Up with CAH: Long-Term Monitoring and Transition to Adulthood

At a Glance

Long-term management of classic CAH requires balancing hormone replacement to support healthy growth while minimizing steroid side effects. Key aspects include tracking growth velocity and bone age, screening males for TARTs, and managing the critical transition from pediatric to adult endocrine care.

Managing Classic Salt-Wasting CAH is a journey that evolves as a child grows. While the early years focus on stabilization and survival, the childhood and adolescent years are dedicated to balancing healthy growth with long-term wellness [1][2].

As your child moves toward adulthood, the “balancing act” shifts from simply replacing hormones to protecting the body from the cumulative effects of both the condition and its treatment [3][4].

Monitoring During Childhood

Growth is the most sensitive indicator of how well CAH is being managed. Your pediatric endocrinologist will track several key markers [2][5]:

  • Growth Velocity: A steady climb on the height and weight charts suggests the steroid dose is “just right.” Rapid spurts or a sudden slowing of growth are signals that the dose may need adjustment [1][2].
  • Bone Age X-rays: Periodic X-rays of the hand and wrist help ensure the bones are not maturing too fast. If androgens (male-type hormones) are too high, the bones “age” quickly, which can lead to a shorter final height [1].
  • The Nuance of Labs: While blood tests for 17-OHP and androstenedione are vital, they are only “snapshots” in time. Because these levels fluctuate wildly throughout the day, a single high result does not always mean the dose needs to be increased [6][7]. Your doctor will look at the trend of labs alongside the growth chart.
  • New Biomarkers: Newer tests, such as 11-oxygenated androgens (like 11-ketotestosterone), are becoming available. These can provide a more accurate and stable picture of adrenal control than traditional tests [8][9].

Specialized Care for Females: Anatomy and Surgery

Baby girls born with Classic CAH may have ambiguous genitalia (external organs that look more masculine) due to high androgen levels in the womb [10]. The internal reproductive organs (uterus and ovaries) are typically normal. Decisions regarding feminizing genitoplasty (surgery to alter the appearance or function of the genitals) are deeply personal and complex.

Your care team should include a pediatric urologist or gynecologist who specializes in differences of sex development (DSD). They can guide you through the latest consensus on surgical timing, long-term sexual health, and preserving reproductive options [11][12]. In adulthood, women with CAH may face reproductive challenges, but with expert management, successful pregnancy is highly possible [13].

Specialized Care for Males: TARTs

Boys and men with Classic CAH have a unique risk for Testicular Adrenal Rest Tumors (TARTs). These are benign (non-cancerous) growths of adrenal-like tissue within the testicles [14][15].

  • Why they happen: When ACTH (the “alarm” hormone from the brain) is chronically high due to under-treatment, it can cause these “rest cells” to grow [14][16].
  • The Risk: If TARTs grow large, they can compress healthy tissue and lead to infertility or low testosterone [17][18].
  • Monitoring: While rare in very young children, screening with scrotal ultrasound is typically recommended starting in late childhood or early adolescence [19][20].

The Transition to Adulthood

The move from a pediatric endocrinologist to an adult specialist is a high-risk period. Many young adults “drop out” of care, which can lead to life-threatening adrenal crises or long-term health issues [21][22].

Long-term health considerations in adulthood include:

  • Cardiometabolic Health: Chronic steroid use can increase the risk of weight gain, high blood pressure, and insulin resistance. Monitoring for cardiovascular risk is essential as patients age [3][23].
  • Bone Density: Over-treatment with steroids over many years can thin the bones (osteoporosis), making regular bone density scans (DEXA) important for adults [3][24].

Taking the Reins

Empowerment is the goal of long-term care. By the time a patient reaches their late teens, they should be able to name their medications, explain their “Sick Day Rules,” and know how to give their own emergency injection [25][26]. A successful transition is not just about changing doctors; it’s about the patient becoming the lead advocate for their own health [4].

Return to Home Page

Common questions in this guide

How is growth monitored in children with classic CAH?
Pediatric endocrinologists monitor growth velocity and perform periodic bone age X-rays to ensure steroid doses are optimal. If androgen levels are too high, bones can age too quickly, potentially reducing a child's final adult height.
What are Testicular Adrenal Rest Tumors (TARTs)?
TARTs are benign growths found in the testicles of some boys and men with CAH. They occur when chronic under-treatment causes high hormone levels that stimulate cell growth, making regular ultrasound screening important to prevent fertility issues.
Will a single abnormal lab result change my CAH steroid dose?
Not necessarily. Hormone levels like 17-OHP fluctuate significantly throughout the day. Doctors typically evaluate long-term trends alongside growth charts rather than relying on a single snapshot in time.
What are the long-term side effects of CAH steroid treatment?
Chronic steroid use can increase the risk of weight gain, high blood pressure, insulin resistance, and reduced bone density (osteoporosis). Regular cardiovascular and bone health screenings become crucial as patients reach adulthood.
What is feminizing genitoplasty for girls with CAH?
It is a specialized surgery for females whose external genitals appear more masculine at birth due to high androgen levels. Decisions about the timing and approach to this surgery are highly personal and made with specialists in differences of sex development (DSD).

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since hormone levels fluctuate throughout the day, how do you use my lab results alongside my growth chart to make dosing decisions?
  2. 2.At what age should we begin annual scrotal ultrasounds to check for testicular adrenal rest tumors (TARTs)?
  3. 3.(For females) What are the pros, cons, and current medical consensus regarding the timing of feminizing genitoplasty?
  4. 4.How are we monitoring for long-term side effects of steroids, such as changes in bone density or metabolic health?
  5. 5.Do you have a formal transition program to help us move from pediatric to adult care when the time comes?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (26)
  1. 1

    Management challenges and therapeutic advances in congenital adrenal hyperplasia.

    Mallappa A, Merke DP

    Nature reviews. Endocrinology 2022; (18(6)):337-352 doi:10.1038/s41574-022-00655-w.

    PMID: 35411073
  2. 2

    Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

    Nokoff NJ, Buchanan C, Barker JM

    The Journal of clinical endocrinology and metabolism 2025; (110(Supplement_1)):S13-S24 doi:10.1210/clinem/dgae563.

    PMID: 39836622
  3. 3

    Epidemiology and Long-Term Adverse Outcomes in Korean Patients with Congenital Adrenal Hyperplasia: A Nationwide Study.

    Kim JH, Choi S, Lee YA, et al.

    Endocrinology and metabolism (Seoul, Korea) 2022; (37(1)):138-147 doi:10.3803/EnM.2021.1328.

    PMID: 35255606
  4. 4

    Management issues of congenital adrenal hyperplasia during the transition from pediatric to adult care.

    Choi JH, Yoo HW

    Korean journal of pediatrics 2017; (60(2)):31-37 doi:10.3345/kjp.2017.60.2.31.

    PMID: 28289431
  5. 5

    Treatment and Follow-up of Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency in Childhood and Adolescence

    Peltek Kendirci HN, Ünal E, Dündar İ, et al.

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):12-22 doi:10.4274/jcrpe.galenos.2024.2024-6-26-S.

    PMID: 39713876
  6. 6

    Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.

    Lawrence N, Bacila I, Dawson J, et al.

    Clinical endocrinology 2022; (97(5)):551-561 doi:10.1111/cen.14796.

    PMID: 35781728
  7. 7

    Adrenal adenoma secreting 17-hydroxyprogesterone mimicking non-classical 21-hydroxylase deficiency.

    Woźniak B, Leszczyńska D, Szatko A, et al.

    Frontiers in endocrinology 2024; (15()):1499836 doi:10.3389/fendo.2024.1499836.

    PMID: 39640880
  8. 8

    Measurement of twenty-one serum steroid profiles by UPLC-MS/MS for the diagnosis and monitoring of congenital adrenal hyperplasia.

    Lee JH, Lee K, Jun SH, et al.

    Journal of mass spectrometry and advances in the clinical lab 2025; (38()):10-17 doi:10.1016/j.jmsacl.2025.10.003.

    PMID: 41143128
  9. 9

    Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency.

    Bacila I, Adaway J, Hawley J, et al.

    The Journal of clinical endocrinology and metabolism 2019; (104(12)):6417-6429 doi:10.1210/jc.2019-00031.

    PMID: 31361321
  10. 10

    Antenatal Diagnosis and Treatment in Congenital Adrenal Hyperplasia Due to 21-hydroxylase Deficiency and Congenital Adrenal Hyperplasia Screening in Newborns

    Yavaş Abalı Z, Kurnaz E, Güran T

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):33-43 doi:10.4274/jcrpe.galenos.2024.2024-6-10-S.

    PMID: 39713885
  11. 11

    Syrian females with congenital adrenal hyperplasia: a case series.

    Dehneh N, Jarjour R, Idelbi S, et al.

    Journal of medical case reports 2022; (16(1)):371 doi:10.1186/s13256-022-03609-y.

    PMID: 36242011
  12. 12

    The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum.

    Maher JY, Gomez-Lobo V, Merke DP

    Reviews in endocrine & metabolic disorders 2023; (24(1)):71-83 doi:10.1007/s11154-022-09770-5.

    PMID: 36399318
  13. 13

    Pregnancy management of IVF-ET pregnancies in a patient with classical 21-hydroxylase deficiency: A case report and review of the literature.

    Yu J, Lu S, Fang L, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2024; (293()):50-56 doi:10.1016/j.ejogrb.2023.12.008.

    PMID: 38104394
  14. 14

    Testicular Adrenal Rest Tumors: Current Insights on Prevalence, Characteristics, Origin, and Treatment.

    Engels M, Span PN, van Herwaarden AE, et al.

    Endocrine reviews 2019; (40(4)):973-987 doi:10.1210/er.2018-00258.

    PMID: 30882882
  15. 15

    Semen quality and testicular adrenal rest tumour development in 46,XY congenital adrenal hyperplasia: the importance of optimal hormonal replacement.

    Rohayem J, Bäumer LM, Zitzmann M, et al.

    European journal of endocrinology 2021; (184(4)):487-501.

    PMID: 33524003
  16. 16

    Testicular Adrenal Rest Tumors in a Patient With Congenital Adrenal Hyperplasia.

    Yu SY, Freed KM

    Cureus 2022; (14(8)):e28350 doi:10.7759/cureus.28350.

    PMID: 36168332
  17. 17

    Testicular adrenal rest tumor in the background of congenital adrenal hyperplasia

    Brzózka Á, Kuthi L, Hajdú E, et al.

    Orvosi hetilap 2020; (161(16)):623-631 doi:10.1556/650.2020.31696.

    PMID: 32323966
  18. 18

    Experience in optimizing fertility outcomes in men with congenital adrenal hyperplasia due to 21 hydroxylase deficiency.

    King TF, Lee MC, Williamson EE, Conway GS

    Clinical endocrinology 2016; (84(6)):830-6 doi:10.1111/cen.13001.

    PMID: 26666213
  19. 19

    Title not available

    Thomsen HH

    Ugeskrift for laeger 2024; (186(11)) doi:10.61409/V12230794.

    PMID: 38533865
  20. 20

    Testicular adrenal rest tumors in children with congenital adrenal hyperplasia.

    Al-Ghamdi WM, Shazly MA, Al-Agha AE

    Saudi medical journal 2021; (42(9)):986-993 doi:10.15537/smj.2021.42.9.20210257.

    PMID: 34470837
  21. 21

    Transition from Paediatric to Adult Care in CAH: 20 Years of Experience at a Tertiary Referral Center.

    Kiewert C, Jedanowski J, Hauffa BP, et al.

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2024; (56(1)):45-50 doi:10.1055/a-2201-6548.

    PMID: 38171370
  22. 22

    Adult endocrinologists' perspectives on transitioning adolescent patients with congenital adrenal hyperplasia.

    Hall ME, Kremen J, Boskey ER, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(8)):722-729 doi:10.1515/jpem-2024-0158.

    PMID: 39008686
  23. 23

    Periaortic fat thickness and cardiovascular risk factors in children with congenital adrenal hyperplasia.

    Akyürek N, Eklioğlu BS, Atabek ME, et al.

    Cardiology in the young 2025; (35(1)):170-174 doi:10.1017/S1047951124036576.

    PMID: 39790002
  24. 24

    Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency.

    Frey KR, Kienitz T, Schulz J, et al.

    Endocrine connections 2018; (7(6)):811-818 doi:10.1530/EC-18-0160.

    PMID: 29720511
  25. 25

    Adrenal Insufficiency in Adults: A Review.

    Vaidya A, Findling J, Bancos I

    JAMA 2025; (334(8)):714-725 doi:10.1001/jama.2025.5485.

    PMID: 40522647
  26. 26

    Treatment and Prevention of Adrenal Crisis and Family Education

    Çamtosun E, Sangün Ö

    Journal of clinical research in pediatric endocrinology 2025; (17(Suppl 1)):80-92 doi:10.4274/jcrpe.galenos.2024.2024-6-12-S.

    PMID: 39713905

This page provides educational information on the long-term management of CAH. Always consult your endocrinologist regarding hormone dosing, surgical decisions, or transitioning into adult care.

Get notified when new evidence is published on Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.